| COVID-19 in children: initial characterization of the pediatric disease AT Cruz, SL Zeichner Pediatrics 145 (6), 2020 | 450 | 2020 |
| Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator H Nakamura, M Lu, Y Gwack, J Souvlis, SL Zeichner, JU Jung Journal of virology 77 (7), 4205-4220, 2003 | 328 | 2003 |
| Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) M Paulose-Murphy, NK Ha, C Xiang, Y Chen, L Gillim, R Yarchoan, ... Journal of virology 75 (10), 4843-4853, 2001 | 266 | 2001 |
| Rapid telomere shortening in children SL Zeichner, P Palumbo, YR Feng, X Xiao, D Gee, J Sleasman, ... Blood, The Journal of the American Society of Hematology 93 (9), 2824-2830, 1999 | 245 | 1999 |
| Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children RI Gafni, R Hazra, JC Reynolds, F Maldarelli, AN Tullio, E DeCarlo, ... Pediatrics 118 (3), e711-e718, 2006 | 214 | 2006 |
| The human immunodeficiency virus type 1 polyadenylylation signal: a 3'long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. A Valsamakis, S Zeichner, S Carswell, JC Alwine Proceedings of the National Academy of Sciences 88 (6), 2108-2112, 1991 | 172 | 1991 |
| Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus JB Purdy, RI Gafni, JC Reynolds, S Zeichner, R Hazra The Journal of pediatrics 152 (4), 582-584, 2008 | 154 | 2008 |
| Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency V Krishnan, SL Zeichner Journal of virology 78 (17), 9458-9473, 2004 | 142 | 2004 |
| Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-κB activation PWP Ng, H Iha, Y Iwanaga, M Bittner, Y Chen, Y Jiang, G Gooden, ... Oncogene 20 (33), 4484-4496, 2001 | 135 | 2001 |
| p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1 T Cherrier, S Suzanne, L Redel, M Calao, C Marban, B Samah, ... Oncogene 28 (38), 3380-3389, 2009 | 128 | 2009 |
| Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat SL Zeichner, JY Kim, JC Alwine Journal of virology 65 (5), 2436-2444, 1991 | 127 | 1991 |
| Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART) SC Martin, PL Wolters, MA Toledo-Tamula, SL Zeichner, R Hazra, ... Developmental neuropsychology 30 (2), 633-657, 2006 | 120 | 2006 |
| Culture-independent evaluation of the appendix and rectum microbiomes in children with and without appendicitis HT Jackson, EF Mongodin, KP Davenport, CM Fraser, AD Sandler, ... PloS one 9 (4), e95414, 2014 | 118 | 2014 |
| COVID-19 in newborns and infants—low risk of severe disease: silver lining or dark cloud? M Rawat, P Chandrasekharan, MD Hicar, S Lakshminrusimha American journal of perinatology 37 (08), 845-849, 2020 | 98 | 2020 |
| Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection R Hazra, RI Gafni, F Maldarelli, FM Balis, AN Tullio, E DeCarlo, CJ Worrell, ... Pediatrics 116 (6), e846-e854, 2005 | 98 | 2005 |
| Changing trends in complications and mortality rates among US youth and young adults with HIV infection in the era of combination antiretroviral therapy G Mirani, PL Williams, M Chernoff, MJ Abzug, MJ Levin, GR Seage III, ... Clinical Infectious Diseases 61 (12), 1850-1861, 2015 | 97 | 2015 |
| Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA MA Laughlin, S Zeichner, D Kolson, JC Alwine, T Seshamma, ... Virology 196 (2), 496-505, 1993 | 91 | 1993 |
| Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression LR Sorbara, F Maldarelli, G Chamoun, B Schilling, S Chokekijcahi, ... Journal of virology 70 (10), 7275-7279, 1996 | 89 | 1996 |
| Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly … P Taylor, C Worrell, SM Steinberg, R Hazra, S Jankelevich, LV Wood, ... Pediatrics 114 (2), e235-e242, 2004 | 87 | 2004 |
| Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir M Lu, J Suen, C Frias, R Pfeiffer, MH Tsai, E Chuang, SL Zeichner Journal of Virology 78 (24), 13637-13652, 2004 | 85 | 2004 |
